PROFILES OF NK CELL SUBSETS ARE ASSOCIATED WITH SUCCESSFUL TYROSINE KINASE INHIBITOR DISCONTINUATION IN CHRONIC MYELOID LEUKEMIA AND CHANGE FOLLOWING INTERFERON TREATMENT
EHA Library, Hao Jiang, 325416
TNF-MEDIATED CML CELL SURVIVAL RESISTS TKI TREATMENT AND THIS CAN BE TARGETED BY IKK2-INHIBITION
EHA Library, Marlena Bütow, 325417
AGE-RELATED DNA DAMAGE RESPONSE (DDR) IN HEMATOPOIETIC STEM CELLS FROM CHRONIC MYELOID LEUKAEMIA PATIENTS WHO ATTEMPTED TKI DISCONTINUATION.
EHA Library, Chiara Manfroni, 325418
ASSESSMENT OF LEUKEMIC STEM CELL CD26+ IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH DEEP MOLECULAR RESPONSE.
EHA Library, Raquel Bengió, 325419
EUTOS EXPERIENCE OF STANDARDISATION OF MOLECULAR MONITORING FOR CML (2016 – 2020). USE OF SECONDARY BCR-ABL1 REFERENCE MATERIALS FOR CONVERSION FACTOR VALIDATION AND ASSESSMENT OF MR4.5 DETECTION
EHA Library, Helen White, 325420
ANALYSIS OF MRNA AND DNA LEVEL OF ATYPICAL BCR-ABL1 TRANSCRIPTS IN CML PATIENTS OUTLINED AN ELIGIBILITY FOR TKI STOPPING
EHA Library, Katerina Machova, 325421
ANALYSIS OF MYELOID MUTATIONS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA AND THEIR ASSOCIATION WITH ADVERSE EVENTS AND RELAPSE AFTER DISCONTINUATION.
EHA Library, Adrian Segura Díaz, 325422
COMPREHENSIVE IMMUNOPROFILE OF NK CELLS FROM CML PATIENTS IN TFR REVEALS A POSSIBLE ROLE OF MEMORY-LIKE NK CELLS
EHA Library, Maria Belen Sanchez, 325423
TARGETING THE LEUKEMIC STEM CELL NICHE BY PI3K INHIBITORS IN CHRONIC MYELOID LEUKEMIA TO OVERCOME LEUKEMIC STEM CELL RESISTANCE
EHA Library, Yüksel Filik, 325424
RARE MUTATIONS IN BCR-ABL THE KINASE DOMAIN IN CRONIC MYELOID LEUKEMIA PATIENTS.
EHA Library, Rocío Delamer, 325425
NEGATIVE PROGNOSTIC IMPACT OF HIGH-RISK ADDITIONAL CYTOGENETIC ABNORMALITIES IN ADDITION TO THE ELTS IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
EHA Library, Camille C.B. Kockerols, 325426
TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE FOLLOWING FRONTLINE NILOTINIB: RESULTS FROM JALSG N-STOP216
EHA Library, Naoto Takahashi, 325427
TREATMENT-FREE REMISSION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE FOLLOWING FRONTLINE DASATINIB: RESULTS FROM JALSG D-STOP216
EHA Library, Yosuke Minami, 325428
COMPARISON OF THE SOKAL AND EUTOS LONG-TERM SURVIVAL SCORES IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA RECEIVING TYROSINE KINASE INHIBITORS
EHA Library, Xiaoshuai Zhang, 325429
ASCIMINIB RESPONSES IN PONATINIB-PRETREATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA
EHA Library, Alejandro Luna, 325430
OUTCOMES BEFORE AND AFTER DOSE REDUCTION IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA RECEIVING BOSUTINIB OR IMATINIB
EHA Library, Michael W Deininger, 325431
SECOND-LINE BOSUTINIB FOR PATIENTS WITH CHRONIC PHASE CHRONIC MYELOID LEUKEMIA : FINAL 10-YEAR RESULTS OF A PHASE 1/2 STUDY
EHA Library, Carlo Gambacorti-Passerini, 325432
TREATMENT-FREE REMISSION IN CHRONIC MYELOID LEUKEMIA PATIENTS TREATED WITH LOW-DOSE TKIS. A FEASIBLE OPTION ALSO IN THE REAL-LIFE SETTING?
EHA Library, Alessandra Iurlo, 325433
COVID-19 IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA: DISEASE OUTCOMES AND FIRST VACCINATION DATA IN RUSSIAN FEDERATION
EHA Library, Ekaterina Chelysheva, 325434
ASSOCIATION OF CREATINE KINASE ELEVATION WITH CLINICAL OUTCOMES IN CHRONIC MYELOID LEUKEMIA
EHA Library, Aniket Bankar, 325435
FRONTLINE TREATMENT APPROACHES FOR CML IN MYELOID BLAST PHASE: A SINGLE-CENTER EXPERIENCE OVER 2 DECADES
EHA Library, Kapil Saxena, 325436
EFFECT OF COMORBIDITIES ON PATIENT RESPONSES WITH FIRST-LINE DASATINIB VERSUS IMATINIB IN CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE: EXPLORATORY POST HOC ANALYSIS OF DASISION
EHA Library, Massimo Breccia, 325437
HYDROXYUREA PRE-TREATMENT IN CHRONIC MYELOID LEUKEMIA PATIENTS: MORE HARM THAN GOOD?
EHA Library, Camille C.B. Kockerols, 325438
FRENCH REAL–LIFE OBSERVATIONAL STUDY 'TOPASE' EVALUATING SAFETY AND EFFICACY OF PONATINIB CONFIRMS INDUCTION OF DEEP MOLECULAR RESPONSES IN 110 RESISTANT OR INTOLERANT CML PATIENTS
EHA Library, Ali Turhan, 325439
WITHDRAWAL SYNDROME AFTER TYROSINE KINASE INHIBITORS DISCONTINUATION IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA
EHA Library, Anna Petrova, 325440
FIRST INTERIM RESULTS OF THE RUSSIAN PROSPECTIVE STUDY OF REDUCTION AND DISCONTINUATION TREATMENT OF TKI (READIT) IN CHRONIC MYELOID LEUKEMIA PATIENTS WITH DEEP MOLECULAR RESPONSE
EHA Library, Margarita Gurianova, 325441
A SURVEY OF HEALTHCARE PROFESSIONALS IN THE UNITED KINGDOM TO DESCRIBE CURRENT PATHWAYS AND MANAGEMENT PRACTICES IN CHRONIC MYELOID LEUKAEMIA: THE ADAPT CML SURVEY
EHA Library, Adam Mead, 325442
TREATMENT ADHERENCE IN CHRONIC MYELOID LEUKEMIA PATIENTS RECEIVING TYROSINE KINASE INHIBITORS
EHA Library, S.M.Amine BENLAZAR, 325443
THE EFFECT OF BODY MASS INDEX ON EFFICACY AND SAFETY OF BOSUTINIB OR IMATINIB IN PATIENTS WITH NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA
EHA Library, Tim Brümmendorf, 325444
EFFICACY AND SAFETY RESULTS FROM AN OPEN-LABEL PHASE 2 STUDY OF PARSACLISIB FOR THE TREATMENT OF AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
EHA Library, Wilma Barcellini, 325445
RARE ANEMIA DISORDERS EUROPEAN EPIDEMIOLOGICAL PLATFORM (RADEEP): DISTRIBUTION OF PATIENTS AFFECTED BY PYRUVATE KINASE DEFICIENCY IN EUROPE
EHA Library, Maria Del Mar Mañú Pereira, 325446
FOSTAMATINIB FOR THE TREATMENT OF WARM ANTIBODY AUTOIMMUNE HEMOLYTIC ANEMIA (WAIHA): UPDATES FROM THE PHASE 2 AND PHASE 3 CLINICAL TRIALS
EHA Library, Dheepika Weerasinghe, 325447
COMPLEX MODES OF INHERITANCE IN HEREDITARY RED BLOOD CELL DISORDERS: A CASE SERIES STUDY OF 155 PATIENTS
EHA Library, Roberta Russo, 325448
INHIBITION OF COMPLEMENT C1S WITH SUTIMLIMAB IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): 1-YEAR INTERIM RESULTS OF THE PHASE 3 CARDINAL STUDY LONG-TERM FOLLOW-UP
EHA Library, Alexander Röth, 325449
CANCER RISK IN PATIENTS WITH WARM AUTOIMMUNE HAEMOLYTIC ANAEMIA - A NATIONWIDE COHORT STUDY
EHA Library, Stinne Tranekaer, 325450
BASELINE CHARACTERISTICS BY AGE OF A GLOBAL COHORT OF PATIENTS DIAGNOSED WITH PYRUVATE KINASE DEFICIENCY – A DESCRIPTIVE ANALYSIS FROM THE PEAK REGISTRY
EHA Library, Paola Bianchi, 325451
EARLY-ONSET OSTEOPENIA AND OSTEOPOROSIS IN PATIENTS WITH PYRUVATE KINASE DEFICIENCY
EHA Library, Hanny Al-Samkari, 325452
PHARMACOLOGIC INHIBITION OF PI3KΔ REDUCES AUTOANTIBODY FORMATION AND IS EFFICACIOUS IN A PRECLINICAL MODEL OF AUTOIMMUNE HEMOLYTIC ANEMIA
EHA Library, Paul Smith, 325453
IMPACT OF OLIPUDASE ALFA ENZYME REPLACEMENT THERAPY ON PULMONARY, VISCERAL AND HEMATOLOGIC MANIFESTATIONS OF ACID SPHINGOMYELINASE DEFICIENCY: 1-YEAR RESULTS OF CLINICAL TRIALS IN CHILDREN AND ADULTS
EHA Library, Maurizio Scarpa, 325454
MITAPIVAT AMELIORATES RED CELL FEATURES AND DECREASES ANEMIA IN BAND 4.2-/- MICE, A MODEL OF HEREDITARY SPHEROCYTOSIS
EHA Library, Alessandro Matte, 325455
BONE MINERAL DENSITY IS STABLE IN ADULTS WITH PYRUVATE KINASE DEFICIENCY RECEIVING LONG-TERM TREATMENT WITH MITAPIVAT
EHA Library, Hanny Al-Samkari, 325456
WARM AUTOIMMUNE HEMOLYTIC ANEMIA IS ASSOCIATED WITH A REGULATORY T CELL DEFICIENCY AND A TH17 POLARIZATION
EHA Library, Marion Ciudad, 325457
SEVERE NEONATAL HAEMOLYTIC ANAEMIA AND SPHEROCYTIC-ELLYPTOCYTOSIS PHENOTYPE DUE TO THE INTERACTION OF THREE NOVEL SPTA1 MUTATIONS
EHA Library, Joan-Lluis Vives-Corrons, 325458
PYRUVATE KINASE DEFICIENCY IN THE RUSSIAN FEDERATION: AN OVERVIEW OF CLINICAL CHARACTERISTICS AND MOLECULAR DEFECTS.
EHA Library, Ekaterina Cherniak, 325459
MOLECULAR HETEROGENEITY OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE (G6PD) DEFICIENCY IN PORTUGAL
EHA Library, Licinio Manco, 325460
SYMPTOMATIC BONE MARROW RECONVERSION: A COMMON FEATURE IN HEREDITARY SPHEROCYTOSIS ?
EHA Library, Camille Pochard, 325461
SOLUBLE CTLA-4 IN CHILDREN WITH IMMUNE CYTOPENIAS: RELATION TO DISEASE ACTIVITY
EHA Library, Sara Makkeyah, 325462
IDENTIFICATION OF A WARM AUTOIMMUNE HEMOLYTIC ANEMIA (WAIHA) POPULATION USING PREDICTIVE ANALYTICS OF A KNOWN CLINICALLY PROFILED COHORT
EHA Library, Keith McCrae, 325463
CLINICAL FEATURES AND TREATMENT RESPONSES IN PEDIATRIC PATIENTS WITH WARM ANTIBODY IMMUNE HEMOLYTIC ANEMIA
EHA Library, Yesim Oymak, 325464
AUTOIMMUNE HEMOLYTIC ANEMIA ASSOCIATED WITH LYMPHOID MALIGNANCIES: REPORT FROM A FRENCH PROSPECTIVE REGISTER.
EHA Library, Sylvain Audia, 325465
FACIT-FATIGUE SUBSCALE OUTCOMES FROM AN ONGOING PHASE 2, OPEN-LABEL STUDY OF THE PHOSPHATIDYLINOSITOL 3-KINASE DELTA (PI3KΔ) INHIBITOR PARSACLISIB IN PATIENTS WITH AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA)
EHA Library, Fabrizio Pane, 325466
CLINICAL AND MOLECULAR CHARACTERISTICS OF IMERSLUND‐GRÄSBECK SYNDROME: FIRST REPORT OF A NOVEL FRAMESHIFT VARIANT IN EXON 11 OF AMN GENE
EHA Library, Mohamed Elshinawy, 325467
USE OF AN NGS PANEL FOR DE DIAGNOSIS OF HEREDITARY HEMOLYTIC ANEMIAS
EHA Library, Irene Zamanillo, 325468
INFLAMMATION AND FATIGUE IN PATIENTS WITH COLD AGGLUTININ DISEASE (CAD): ANALYSIS FROM THE PHASE 3 CARDINAL STUDY
EHA Library, Ilene Weitz, 325469
MORTALITY AMONG VETERANS WITH A DIAGNOSIS OF PYRUVATE KINASE DEFICIENCY: A REAL-WORLD STUDY USING US VETERANS HEALTH ADMINISTRATION DATA
EHA Library, Erin Zagadailov, 325470
FEASIBILITY STUDY: USING DRIED BLOOD SPOTS AS A DNA SOURCE TO SCREEN FOR PYRUVATE KINASE CAUSING VARIANTS
EHA Library, Barnaby Clark, 325471
USEFULNESS OF NGS TECHNIQUES FOR PYRUVATE KINASA DEFICIENCY (PKD) DIAGNOSIS IN SPAIN
EHA Library, Marta Morado, 325472
STUDY DESIGN OF A PHASE 2/3 RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF NIPOCALIMAB, AN FCRN ANTAGONIST, IN WARM AUTOIMMUNE HEMOLYTIC ANEMIA (WAIHA)
EHA Library, Irina Murakhovskaya, 325473
WARM AUTOIMMUNE HEMOLYTIC ANEMIA : A RETROSPECTIVE ANALYSIS OF 115 PATIENTS
EHA Library, BECHIR ACHOUR, 325474
COMPARISON BETWEEN THE DIFFERENT REGIMENS AND PHARMACOLOGICAL FORMS OF CORTICOSTEROID AS FIRST-LINE THERAPY OF AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA): RESULTS OF THE PROSPECTIVE OBSERVATIONAL COHORT.
EHA Library, Ghada Abdallah, 325475
PHENOTYPIC, TRANSCRIPTIONAL AND FUNCTIONAL ANALYSIS OF CD19 CAR-T CELLS: SENESCENT/EXHAUSTED PHENOTYPE PREDICTS RESPONSE OF B CELL LYMPHATIC MALIGNANCIES
EHA Library, Katia Beider, 325476
IMMUNE REGULATORY PROTEINS MODULATE FIBROSIS AND INFLAMMATION IN SCLERODERMATOUS GRAFT-VS-HOST DISEASE
EHA Library, Gerlinde Wernig, 325477
IMPROVED LEUKEMIA CLEARANCE AFTER ADOPTIVE TRANSFER OF NK CELLS ENGINEERED WITH THE BONE MARROW HOMING RECEPTOR CXCR4
EHA Library, Filip Segerberg, 325478
HARNESSING EXHAUSTED, TUMOR-SPECIFIC T CELLS TO GENERATE A T-CELL RECEPTORS LIBRARY FOR ADOPTIVE T CELL THERAPY IN BLOOD MALIGNANCIES
EHA Library, Francesco Manfredi, 325479
VALIDATION OF AN IL-1RAP CART-CELLS PRECLINICAL « GMP-LIKE » PRODUCTION PROCESS BEFORE AN UPCOMING FIRST IN HUMAN PHASE I CLINICAL TRIAL.
EHA Library, Xavier Roussel, 325480
EXPLORING A SAFE AND EFFECTIVE 'OFF-THE-SHELF' CELL-BASED IMMUNOTHERAPY FOR THE TREATMENT OF MULTIPLE MYELOMA USING NON-IRRADIATED CAR NK-92MI CELLS
EHA Library, Elena Maroto Martín, 325481
CAR-TREG THERAPY FOR SYSTEMIC LUPUS ERYTHEMATOSUS
EHA Library, Matteo Doglio, 325482
MONITORING COMMERCIAL ANTI-CD19 CAR T-CELL PRODUCT EXPANSION KINETICS: REAL-WORLD APPLICATIONS OF A NOVEL DROPLET DIGITAL PCR ASSAY AND OF MULTIPARAMETRIC FLOW CYTOMETRY
EHA Library, Chiara Monfrini, 325483
SELECTION, EXPANSION, AND NEW PRETREATMENT OF HUMAN NATURAL KILLER CELLS WITH ANTI-CD38 MONOCLONAL ANTIBODY FOR EFFICIENT TREATMENT OF MULTIPLE MYELOMA.
EHA Library, Juli R. Bagó, 325484
DETERMINANTS OF IN VIVO EXPANSION OF CD19 SPECIFIC CAR T-CELLS IN LARGE B-CELL LYMPHOMA: SINGLE CENTER IMMUNMONITORING RESULTS
EHA Library, Viktoria Blumenberg, 325485
MONITORING CAR-T CELL IN B-CELL LYMPHOMA PATIENTS THROUGH SINGLE CHAIN VARIABLE FRAGMENT QPCR
EHA Library, Diego Carbonell, 325486
CRISPR/CAS9 MEDIATED TCR EXCHANGE IN CORD BLOOD CD8+ T CELLS POTENTIALLY INCREASES GVL AND DECREASE GVHD
EHA Library, Vania Lo Presti, 325487
THE IMMUNOREGULATORY FUNCTIONS OF EXOSOME DERIVED FROM MESENCHYMAL STEM CELLS (MSCS) THAT GENETICALLY MODIFIED BY ADENO-ASSOCIATED VIRUS (AAV)
EHA Library, Li Liu, 325488
CAR-T CELL IN DIFFUSE LARGE B-CELL AND PRIMARY MEDIASTINAL LYMPHOMAS IN REAL LIFE SETTING: A REPORT FROM THE PROSPECTIVE OBSERVATIONAL STUDY OF THE ITALIAN SOCIETY OF HEMATOLOGY.
EHA Library, Annalisa Chiappella, 325489
CLINICAL OUTCOMES IN ADULTS WITH HEMOPHILIA B WITH AND WITHOUT PRE-EXISTING NEUTRALIZING ANTIBODIES TO AAV5: 6 MONTH DATA FROM THE PHASE 3 ETRANACOGENE DEZAPARVOVEC HOPE-B GENE THERAPY TRIAL
EHA Library, Frank Leebeek, 325490
IMMUNOTHERAPY USING A 3RD GENERATION CD20 TARGETED CAR T-CELL (MB-106) FOR TREATMENT OF B-CELL NON-HODGKIN LYMPHOMA (B-NHL) AND CHRONIC LYMPHOCYTIC LEUKEMIA (CLL)
EHA Library, Mazyar Shadman, 325491
CTX001 FOR TRANSFUSION-DEPENDENT Β-THALASSEMIA: SAFETY AND EFFICACY RESULTS FROM THE ONGOING CLIMB THAL-111 STUDY OF AUTOLOGOUS CRISPR-CAS9-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS
EHA Library, Franco Locatelli, 325492
FACTORS ASSOCIATED WITH PROGRESSION-FREE SURVIVAL (PFS) OF ADULT AND PEDIATRIC PATIENTS WITH RELAPSED / REFRACTORY B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA TREATED WITH ARI-0001 CART19 THERAPY.
EHA Library, Valentín Ortiz-Maldonado, 325493
CTX001 FOR SICKLE CELL DISEASE: SAFETY AND EFFICACY RESULTS FROM THE ONGOING CLIMB SCD-121 STUDY OF AUTOLOGOUS CRISPR-CAS9-MODIFIED CD34+ HEMATOPOIETIC STEM AND PROGENITOR CELLS
EHA Library, Stephan Grupp, 325494
REAL-WORLD TREATMENT WITH CAR T-CELL THERAPY OF UNITED STATES (US) PATIENTS WITH LARGE B CELL LYMPHOMA (LBCL)
EHA Library, Andrew Klink, 325495
T CELL LINEAGE MIXED CHIMERISM IN ACUTE LEUKAEMIA/MDS- IS IT PROGNOSTIC - A SINGLE CENTRE RETROSPECTIVE STUDY
EHA Library, Vipul Sheth, 325496
OBJECTIVE RESPONSE AT LOW DOSE IN THE FIRST-IN-HUMAN IMMUNICY-1 TRIAL EVALUATING NON-GENE EDITED ALLOGENEIC CYAD-211 ANTI-BCMA CAR-T PRODUCT IN RELAPSED OR REFRACTORY MULTIPLE MYELOMA
EHA Library, Sebastien Anguille, 325497
PRELIMINARY ANALYSIS OF A PHASE 1 STUDY OF NEXI-002 AUTOLOGOUS MULTI-AGENT-SPECIFIC CD8+ T CELLS FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA (RRMM)
EHA Library, Andrew Kin, 325498
A 10 YEAR RETROSPECTIVE SERIES OF PERIPHERAL BLOOD STEM AND PROGENITOR CELL COLLECTION IN PEDIATRIC CANDIDATES FOR AUTOLOGOUS EX-VIVO GENE THERAPY
EHA Library, Daniele Canarutto, 325499
DIFFERENCES IN SERUM CYTOKINE LEVELS AND PEAK TIMES BETWEEN CD19 AND CD7 CAR-T TREATMENT
EHA Library, Dongchu Wang, 325500
INTENTION TO TREAT VERSUS MODIFIED INTENTION-TO-TREAT ANALYSIS IN BCMA AND CD-19 CHIMERIC ANTIGEN RECEPTOR TRIALS: A SYSTEMATIC REVIEW AND META-ANALYSIS
EHA Library, Ghulam Rehman Mohyuddin, 325501
LONG TERM CYTOPENIA AND INFECTIONS IN PATIENTS TREATED WITH ANTI-CD19 CAR T-CELLS: AN ANALYSIS OF BONE MARROW AND CLINICAL RISK FACTORS
EHA Library, Anna Guidetti, 325502
TOWARDS PATIENT-SPECIFIC DOSING OF MELPHALAN CONDITIONING FOR ARU-1801, A NOVEL GENE THERAPY FOR TREATMENT OF SICKLE CELL DISEASE
EHA Library, Brendan Johnson, 325503
FACILITY READINESS ASSESSMENT FOR CAR-T TREATMENT IN AUSTRALIA: NHL PERSPECTIVE
EHA Library, Pravin Bagul, 325504
ANAKINRA PROPHYLAXIS IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA RECEIVING ORVACABTAGENE AUTOLEUCEL (ORVA-CEL)
EHA Library, Luciano J. Costa, 325505
A PROSPECTIVE PHASE I/IIA TRIAL TO EVALUATE THE SAFETY AND EFFICACY OF GTA002, AN OFF-THE-SHELF, EX VIVO-CULTURED ALLOGENEIC NK CELL PREPARATION IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (WINK TRIAL)
EHA Library, Jakob Passweg, 325506
'MYTCELL': A SMARTPHONE APPLICATION GUIDES MANAGEMENT OF CAR T-CELL & BITE RELATED TOXICITIES
EHA Library, Viktoria Blumenberg, 325507
DIFFERENTIAL HEMATOPOIETIC SUPPORT ACROSS THE ADIPOCYTIC DIFFERENTIATION AXIS: PHARMACOLOGICAL MODULATION TO ACCELERATE HEMATOPOIETIC RECOVERY
EHA Library, Frédérica Schyrr, 325508
INTEGRATED SINGLE CELL ANALYSIS IDENTIFIES UNIQUE MOLECULAR AND FUNCTIONAL FEATURES OF EXTRAMEDULLARY HAEMATOPOIESIS IN HUMANS
EHA Library, Nicole Mende, 325509
A STAT5B-CD9 AXIS DETERMINES SELF-RENEWAL IN HEMATOPOIETIC AND LEUKEMIC STEM CELLS
EHA Library, Veronika Sexl, 325510
DENATONIUM AS BITTER TASTE RECEPTOR AGONIST AFFECTS THE CLONOGENIC CAPACITY AND DIFFERENTIATION OF HEMATOPOIETIC STEM CELLS
EHA Library, Valentina Pensato, 325511
CLONAL HAEMATOPOIESIS: USING LONGITUDINAL COHORT DATA TO STUDY THE AGEING HUMAN HAEMATOPOIETIC SYSTEM
EHA Library, Kristina Kirschner, 325512
CHIP CLONE SIZE CORRELATES WITH EPIGENETIC AGE ACCELERATION
EHA Library, Jasper David Feldkamp, 325513
CHANGES IN BONE MARROW STROMAL MICROENVIRONMENT PROGENITOR CELLS IN PATIENTS WITH HEMOBLASTOSIS
EHA Library, Nataliya Petinati, 325514
PREVALENCE AND CLINICAL IMPACT OF CLONAL HEMATOPOIESIS OF INDETERMINATE POTENTIAL (CHIP) IN PATIENTS UNDERGOING HEART TRANSPLANTATION.
EHA Library, Victoria Panagiota, 325515

Anonymous User Privacy Preferences

Strictly Necessary Cookies (Always Active)

MULTILEARNING platforms and tools hereinafter referred as “MLG SOFTWARE” are provided to you as pure educational platforms/services requiring cookies to operate. In the case of the MLG SOFTWARE, cookies are essential for the Platform to function properly for the provision of education. If these cookies are disabled, a large subset of the functionality provided by the Platform will either be unavailable or cease to work as expected. The MLG SOFTWARE do not capture non-essential activities such as menu items and listings you click on or pages viewed.


Performance Cookies

Performance cookies are used to analyse how visitors use a website in order to provide a better user experience.



Google Analytics is used for user behavior tracking/reporting. Google Analytics works in parallel and independently from MLG’s features. Google Analytics relies on cookies and these cookies can be used by Google to track users across different platforms/services.



{$cookies-google-tag-manager-description}


Save Settings